BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2162 related articles for article (PubMed ID: 22419778)

  • 1. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.
    Vandenberg LN; Colborn T; Hayes TB; Heindel JJ; Jacobs DR; Lee DH; Shioda T; Soto AM; vom Saal FS; Welshons WV; Zoeller RT; Myers JP
    Endocr Rev; 2012 Jun; 33(3):378-455. PubMed ID: 22419778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.
    Gore AC; Chappell VA; Fenton SE; Flaws JA; Nadal A; Prins GS; Toppari J; Zoeller RT
    Endocr Rev; 2015 Dec; 36(6):593-602. PubMed ID: 26414233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.
    Gore AC; Chappell VA; Fenton SE; Flaws JA; Nadal A; Prins GS; Toppari J; Zoeller RT
    Endocr Rev; 2015 Dec; 36(6):E1-E150. PubMed ID: 26544531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-specific enhanced behavioral toxicity induced by maternal exposure to a mixture of low dose endocrine-disrupting chemicals.
    Sobolewski M; Conrad K; Allen JL; Weston H; Martin K; Lawrence BP; Cory-Slechta DA
    Neurotoxicology; 2014 Dec; 45():121-30. PubMed ID: 25454719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenerational epigenetic effects from male exposure to endocrine-disrupting compounds: a systematic review on research in mammals.
    Van Cauwenbergh O; Di Serafino A; Tytgat J; Soubry A
    Clin Epigenetics; 2020 May; 12(1):65. PubMed ID: 32398147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made?
    Rhomberg LR; Goodman JE
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):130-3. PubMed ID: 22750031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human exposure to endocrine disrupting chemicals: effects on the male and female reproductive systems.
    Sifakis S; Androutsopoulos VP; Tsatsakis AM; Spandidos DA
    Environ Toxicol Pharmacol; 2017 Apr; 51():56-70. PubMed ID: 28292651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to endocrine disrupting chemicals and neurodevelopmental alterations.
    Pinson A; Bourguignon JP; Parent AS
    Andrology; 2016 Jul; 4(4):706-22. PubMed ID: 27285165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of individual and combined estrogenic effects of bisphenol, nonylphenol and diethylstilbestrol in immature rats with mathematical models.
    Mao W; Song Y; Sui H; Cao P; Liu Z
    Environ Health Prev Med; 2019 May; 24(1):32. PubMed ID: 31084616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to endocrine disrupting compounds via the food chain: Is packaging a relevant source?
    Muncke J
    Sci Total Environ; 2009 Aug; 407(16):4549-59. PubMed ID: 19482336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minireview: Endocrine Disruptors: Past Lessons and Future Directions.
    Schug TT; Johnson AF; Birnbaum LS; Colborn T; Guillette LJ; Crews DP; Collins T; Soto AM; Vom Saal FS; McLachlan JA; Sonnenschein C; Heindel JJ
    Mol Endocrinol; 2016 Aug; 30(8):833-47. PubMed ID: 27477640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male pubertal development: are endocrine-disrupting compounds shifting the norms?
    Zawatski W; Lee MM
    J Endocrinol; 2013; 218(2):R1-12. PubMed ID: 23709001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clash of old and new scientific concepts in toxicity, with important implications for public health.
    Myers JP; Zoeller RT; vom Saal FS
    Environ Health Perspect; 2009 Nov; 117(11):1652-5. PubMed ID: 20049113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
    Wan MLY; Co VA; El-Nezami H
    Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review.
    Melnick R; Lucier G; Wolfe M; Hall R; Stancel G; Prins G; Gallo M; Reuhl K; Ho SM; Brown T; Moore J; Leakey J; Haseman J; Kohn M
    Environ Health Perspect; 2002 Apr; 110(4):427-31. PubMed ID: 11940462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons.
    Lee DH; Jacobs DR
    J Clin Epidemiol; 2019 Mar; 107():107-115. PubMed ID: 30543909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of endocrine disrupting chemicals on the vitronectin-receptor (integrin α
    Kenda M; Pečar Fonović U; Kos J; Sollner Dolenc M
    Toxicol In Vitro; 2022 Mar; 79():105275. PubMed ID: 34801682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do hormone-modulating chemicals impact on reproduction and development of wild amphibians?
    Orton F; Tyler CR
    Biol Rev Camb Philos Soc; 2015 Nov; 90(4):1100-17. PubMed ID: 25335651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the Health Effects of Bisphenol A: Overwhelming Evidence of Harm.
    Vom Saal FS; Vandenberg LN
    Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33516155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intersection of neurotoxicology and endocrine disruption.
    Weiss B
    Neurotoxicology; 2012 Dec; 33(6):1410-1419. PubMed ID: 22659293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 109.